Usefulness of the Psoriatic Arthritis Screening and Evaluation Questionnaire to Monitor Disease Activity in Management of Patients with Psoriasis: Findings from the EPI-PSODE Studyopen access
- Authors
- Choe, YB[Choe, Yong Beom]; Park, CJ[Park, Chul Jong]; Yu, DY[Yu, Dae Young]; Kim, Y[Kim, Youngdoe]; Ju, HJ[Ju, Hyun Jeong]; Youn, SW[Youn, Sang Woong]; Lee, JH[Lee, Joo-Heung]; Kim, BS[Kim, Byung Soo]; Seo, SJ[Seo, Seong Jun]; Yun, SK[Yun, Seok-Kweon]; Park, J[Park, Joonsoo]; Kim, NI[Kim, Nack In]; Youn, JI[Youn, Jai Il]; Lee, SJ[Lee, Seok-Jong]; Lee, MG[Lee, Min-Geol]; Kim, KJ[Kim, Kwang Joong]; Ro, YS[Ro, Young Suck]; Song, HJ[Song, Hae Jun]; Shin, BS[Shin, Bong Seok]; Ahn, SK[Ahn, Sung Ku]; Lee, JY[Lee, Ji Yeoun]; Won, YH[Won, Young Ho]; Jang, MS[Jang, Min Soo]; Kim, KH[Kim, Ki Ho]; Kim, MH[Kim, Myung Hwa]; Kim, TY[Kim, Tae Yoon]; Choi, JH[Choi, Jee-Ho]
- Issue Date
- Feb-2019
- Publisher
- KOREAN DERMATOLOGICAL ASSOC
- Keywords
- Arthritis; Psoriatic
- Citation
- ANNALS OF DERMATOLOGY, v.31, no.1, pp.29 - 36
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- ANNALS OF DERMATOLOGY
- Volume
- 31
- Number
- 1
- Start Page
- 29
- End Page
- 36
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/11171
- DOI
- 10.5021/ad.2019.31.1.29
- ISSN
- 1013-9087
- Abstract
- Background: Psoriasis and psoriatic arthritis (PsA) are included in the group of immune-mediated inflammatory diseases (IMIDs) caused by systemic inflammation; however, indicators for monitoring inflammatory activity in patients with psoriasis, such as the Psoriasis Area and Severity Index (PASI), are limited. Objective: To determine whether the Psoriatic Arthritis Screening and Evaluation (PASE) questionnaire can be used to monitor disease activity in patients with psoriasis. Methods: This was a multicenter, non-interventional, cross-sectional study. Demographic factors and PASI and PASE scores were collected to investigate associations between each. Results: PASE data were available for 1,255 patients, of whom 498 (39.7%) had a score of >= 37. Compared with the group with PASE score < 37, the group with score >= 37 had a higher proportion of women (34.9% vs. 48.8%, p<0.0001), older mean age at diagnosis (36.4 vs. 41.7 years, p<0.0001), more severe disease activity using PASI and body surface area measures (p=0.0021 and p=0.0008, respectively), and higher mean body mass index (23.7 vs. 24.1, p=0.0411). In a multiple linear regression model, PASE score was positively associated with cutaneous disease activity (p<0.0001). Conclusion: After risk-adjustment, PASE was positively associated with PASI, which suggests that PASE can be sensitive to disease activity. Since psoriasis is regarded as one of the IMIDs, PASE may be utilized as a tool not only to screen PsA but also to monitor disease activity.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/11171)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.